Serum ceruloplasmin oxidase activity and malondialdehyde level in experimental abdominal compartment syndrome-induced rats;Deneysel abdominal kompartman sendromu olusturulan siçanlarda serum malondialdehid düzeyi ile seruloplazmin oksidaz aktivitesi

Turkiye Klinikleri Journal of Medical Sciences

Volumn 30, Issue 2, 2010, Pages 669-673

  Böyük, Abdullah ^a   Çikman, Öztekin ^a   Behcet A L ^b   Balik, A Ahmet ^b   Taysi, Seyithan ^b  

^a Elaziǧ Research and Educational Hospital ^*  (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Ceruloplasmin; Compartment syndromes

Indexed keywords

CERULOPLASMIN; MALONALDEHYDE;

ABDOMINAL COMPARTMENT SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL RAT; HEART; INTRAABDOMINAL HYPERTENSION; MALE; NONHUMAN; RAT;

EID: 77952893331     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: 10.5336/medsci.2008-8323     Document Type: Article

References (26)

1. Calzia E, Klaus S, Sugrue M. Decompression in abdominal compartment syndrome: how early is early? Intensive Care Med 2007;33(8): 1319-21.
2. Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, De Waele J, Ivatury R. Abdominal compartment syndrome: it's time to pay attention! Intensive Care Med 2006;32(11):1912-4.
3. Sener G, Kaçmaz A, User Y, Ozkan S, Tilki M, Yeǧen BC. Melatonin ameliorates oxidative organ damage induced by acute intra-abdominal compartment syndrome in rats. J Pineal Res 2003;35(3):163-8.
4. Aksoy H, Taysi S, Altinkaynak K, Bakan E, Bakan N, Kumtepe Y. Antioxidant potential and transferrin, ceruloplasmin and lipid peroxidation levels in women with preeclampsia. J Investig Med 2003;51(5):284-7.
5. Memisoǧullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003;21(3):291-6.
6. Mariani E, Cornacchiola V, Polidori MC, Mangialasche F, Malavolta M, Cecchetti R, et al. Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zincstatus: results from the Zincage Project. Biogerontology 2006;7(5-6):391-8.
7. Sedlák E, Zoldák G, Wittung-Stafshede P. Role of copper in thermal stability of human.ceruloplasmin. Biophys J 2008;94(4):1384-91.
8. Frieden E, Hsieh HS. Ceruloplasmin: the copper transport protein with essential oxidase.activity. Adv Enzymol Relat Areas Mol Biol 1976;44:187-236.
9. Gutteridge JM. Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation. FEBS Lett 1983;157(1):37-40.
10. Bianchini A, Musci G, Calabrese L. Inhibition of endothelial nitric-oxide synthase by ceruloplasmin. J Biol Chem 1999;274(29):20265-70.
11. Jain SK, McVie R, Duett J, Herbst JJ. Eryt-hrocyte membrane lipid peroxidation and glycosylated hemoglobinin diabetes. Diabetes 1989;38(12):1539-43.
12. Schosinsky KH, Lehmann HP, Beeler MF. Measurement of ceruloplasmin from its oxidase.activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 1974;20(12):1556-63.
13. Gutt CN, Schmandra TC. Portal venous flow during CO(2) pneumoperitoneum in the rat. Surg Endosc 1999;13(9):902-5.
14. Caldwell CB, Ricotta JJ. Changes in visceral blood flow with elevated intraabdominal pressure. J Surg Res 1987;43(1):14-20.
15. Yaǧmur Y, Gedik E, Girgin S. [Abdominal compartment syndrome: current definitions and treatment]. Turkiye Klinikleri J Surg Med Sci 2007;3(28):80-5.
16. Yerlikaya HF, Mehmetoǧlu I, Kurban S, Yilmaz G. [Investigation of serum nitric oxide, oxidized low density lipoprotein and total antioxidant activity in obese subjects and healthy controls]. Turkiye Klinikleri J Med Sci 2008;28(2):123-7.
17. Anderson RJ, Cronin RE, McDonald KM, Schrier RW. Mechanisms of portal hypertension-induced alterations in renal hemodynamics, renal water excretion, and reninsecretion. J Clin Invest 1976;58(4):964-70.
18. Demirbaǧ R, Yilmaz R, Güzel S, Çelik H, Koçyiǧit A, Erel Ö. [Effects of treadmill exercise test on oxidative/antioxidative parameters and DNA damage]. Anadolu Kardiyol Derg 2006; 6(2):135-40.
19. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995;92(7):2539-43.
20. Kono S, Miyajima H. Molecular and pathological basis of aceruloplasminemia. Biol Res 2006;39(1):15-23.
21. Miyajima H, Fujimoto M, Kohno S, Kaneko E, Gitlin JD. CSF abnormalities in patients with aceruloplasminemia. Neurology 1998;51(4): 1188-90.
22. Taysi S, Polat F, Gul M, Sari RA, Bakan E. Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 2002;21(5):200-4.
23. Taysi S, Demircan B, Akdeniz N, Atasoy M, Sari RA. Oxidant/antioxidant status in men with Behçet's disease. Clin Rheumatol 2007;26(3):418-22.
24. Sener G, Paskaloǧlu K, Sehirli AO, Dülger GA, Alican I. The effects of melatonin on ischemia-reperfusion induced changes in rat corpus cavernosum. J Urol 2002;167(6):2624-7.
25. Werns SW, Lucchesi BR. Free radicals and ischemic tissue injury. Trends Pharmacol Sci 1990;11(4):161-6.
26. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 1995;57:311-32.